ABOUT ALTASCIENCES

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.

FEATURED CONTENT

FEATURED WEBINARS

CONTACT INFORMATION

Altasciences

1510 Delp Drive

Harleysville, PA 19438

UNITED STATES

Contact: contact@altasciences.com

FEATURED SOLUTIONS

  • Recognized globally as a CNS Center of Excellence, Altasciences has completed more than 200 preclinical and clinical neurological studies, in addition to providing formulation, manufacturing, and analytical testing services, as well as bioanalytical support. Speak with one of their experts!

  • Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.

     

    View the complete resource library.

     

    Contact an Altasciences expert to learn more about their comprehensive clinical solution.

  • Whether you’re pursuing an IND submission in the U.S. or a CTA in Canada and Europe, our integrated solutions model provides comprehensive regulatory support at every drug development stage.

  • We specialize in DDI studies, including stand-alone and 'cocktail' designs, assessing multiple CYP enzymes or transporters in single studies, from simple crossovers to complex adaptive trials.

  • Altasciences has successfully designed, conducted, analyzed, and reported numerous clinical trials focused on renal and hepatic impairment across a wide range of therapeutic areas.

  • Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.

  • Did you know? Altasciences’ clinical facilities are integrated with state-of-the-art flow cytometry laboratories. With our deep expertise in regulated cellular analysis, our team ensures that every step — from sample collection and processing to transport and analysis — is optimized for precision and speed.

  • Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.

  • Need help with inclusion/exclusion criteria for your Phase 2/3 protocol or an unexpected FDA post-marketing amendment? Altasciences offers reliable solutions with a quick start-up.

  • With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.

FEATURED AUDIO